Does a history of non-vertebral fracture identify women without osteoporosis for treatment?

Journal of General Internal Medicine

Volumn 23, Issue 8, 2008, Pages 1177-1181

  Ryder, Kathryn M ^a,f   Cummings, Steven R ^b   Palermo, Lisa ^b   Satterfield, Suzanne ^a   Bauer, Douglas C ^b   Feldstein, Adrianne C ^c   Schousboe, John T ^d   Schwartz, Ann V ^b   Ensrud, Kristine ^d,e  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f Division of General Internal Medicine   (United States)

Author keywords

Fracture; Osteoporosis; Women

Indexed keywords

ALENDRONIC ACID; PLACEBO;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CONTROLLED STUDY; FEMALE; FEMUR NECK FRACTURE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE;

AGED; AGED, 80 AND OVER; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PLACEBOS; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 49649126611     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0622-0     Document Type: Article

References (37)

1. AC Looker ES Orwoll CC Johnston Jr 1997 Prevalence of low femoral bone density in older U.S. adults from NHANES III J Bone Miner Res 12 1761 1768
2. SA Wainwright LM Marshall KE Ensrud 2005 Hip fracture in women without osteoporosis J Clin Endocrinol Metab 90 2787 2793
3. KM Sanders JA Pasco AM Ugoni 1998 The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community J Bone Miner Res 13 1337 1342
4. SCE Schuit M van der Klift AEAM Weel 2004 Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study Bone 34 195 202
5. KL Stone DG Seeley L-Y Lui 2003 BMD at multiple sites and risk of fractures of multiple types: long-term results from the Study of Osteoporotic Fractures J Bone Miner Res 18 1947 1954
6. ES Siris YT Chen TA Abbott 2004 Bone mineral density thresholds for pharmacological intervention to prevent fractures Arch Intern Med 164 1108 1112
7. CM Klotzbuecher PD Ross PB Landsman TA Abbott III M Berger 2000 Patients with prior fracture have an increased risk of future fractures: a summary of the literature and statistical synthesis J Bone Miner Res 15 721 739
8. SR Cummings MC Nevitt WS Browner 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group N Engl J Med 332 767 773
9. T Nguyen P Sambrook P Kelly 1993 Prediction of osteoporotic fractures by postural instability and bone density BMJ 307 1111 1115
10. P Dargent-Molina F Faviier H Grandjean 1996 Fall-related factors and risk of hip fracture: the EPIDOS prospective study Lancet 348 145 149
11. National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 1998.
12. American Association of Clinical Endocrinology 2003 Medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates from 2003 Endocrine Pract 9 544 564
13. ES Siris HK Genant AJ Laster 2007 Enhanced prediction of fracture risk combining vertebral fracture status and BMD Osteoporos Int 18 761 770
14. KE Ensrud DM Black L Palermo 1997 Treatment with alendronate prevents fractures in women at highest risk Arch Intern Med 157 2614 2617
15. SA Quandt DE Thompson DL Schneider 2005 Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of -1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial Mayo Clin Proc 80 343 349
16. SR Cummings DM Black DE Thompson 1998 Effect of alendronate on risk of fracture in women with low bone mineral density but without vertebral fractures JAMA 280 2077 2082
17. JT Schousboe JA Nyman RL Kane KE Ensrud 2005 Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women Ann Intern Med 142 734 741
18. JT Schousboe KE Ensrud JA Nyman 2005 Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy Osteoporosis Int 16 1883 1893
19. MR McClung P Geusens PD Miller 2001 Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group N Engl J Med 344 333 340
20. E Sornay-Rendu F Munoz P Garnero 2005 Identification of osteopenic women at high risk of fracture: the OFELY study J Bone Miner Res 20 1813 1819
21. O Johnell JA Kanis A Oden 2004 Fracture risk following an osteoporotic fracture Osteoporos Int 15 175 179
22. PD Miller S Barlas SK Brenneman 2004 An approach to identifying osteopenic women at increased short-term risk of fracture Arch Intern Med 164 1113 1120
23. DM Black TF Reiss MC Nevitt 1993 Design of the fracture intervention trial Osteoporos Int 3 suppl 3 S29 S39
24. Genant HK, Jergas M, van Kuijk C, eds. Vertebral Fracture in Osteoporosis. San Francisco, Calif: Radiology Research and Educational Foundation; 1995:131-147.
25. ST Harris NB Watts HK Genant 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis JAMA 282 1344 1352
26. J Reginster HW Minne OH Sorensen 2000 Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Osteoporos Int 11 83 91
27. CH Chestnut III A Skag C Christiansen 2004 Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis J Bone Miner Res 19 1241 1249
28. RM Neer CD Arnaud JR Zanchetta 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434 1441
29. JA Cauley J Robbins Z Chen 2003 Effects of estrogen plus progestin on risk of fracture and bone mineral density. the Women's Health Initiative Randomized Trial JAMA 290 1729 1738
30. E Barrett-Connor L Mosca P Collins 2006 Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women N Engl J Med 355 125 137
31. KW Lyles CS Colon-Emeric JS Magaziner 2007 Zoledronic acid and clinical fractures and mortality after hip fracture N Engl J Med 357 1799 1809
32. SJ Gallacher AP Gallagher C McQuillian 2007 The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures Osteoporos Int 18 185 192
33. DC Bauer P Garnero MC Hochberg 2006 Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the Fracture Intervention Trial J Bone Miner Res 21 292 299
34. JT Schousboe DC Bauer KA Nyman 2007 Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy Osteoporos Int 18 201 210
35. MC Nevitt SR Cummings WS Browner 1992 The accuracy of self-report of fractures in elderly women: evidence from a prospective study Am J Epidemiol 135 490 499
36. YA Hundrup S Hoidrop EB Obel NK Rasmussen 2004 The validity of self-reported fractures among Danish female nurses: comparison with fractures registered in the Danish National Hospital Register Scand J Pub Health 32 136 143
37. RQ Ivers RG Cummings P Mitchell AJ Peduto 2002 The accuracy of self-reported fractures in older people J Clin Epidemiol 55 452 457